18F-TPP for Cardiac Arrhythmias

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Cardiac Arrhythmias18F-TPP - Drug
Eligibility
21 - 80
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether PET-MR imaging can improve treatment for heart failure and irregular heart rate.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 5 years

5 years
TPP imaging in Ventricular Arrhythmia

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

3 Treatment Groups

Control
1 of 3
Arrhythmia
1 of 3
Treatment Failure
1 of 3

Active Control

Experimental Treatment

150 Total Participants · 3 Treatment Groups

Primary Treatment: 18F-TPP · No Placebo Group · Phase 2

Arrhythmia
Drug
Experimental Group · 1 Intervention: 18F-TPP · Intervention Types: Drug
Treatment Failure
Drug
Experimental Group · 1 Intervention: 18F-TPP · Intervention Types: Drug
Control
Drug
ActiveComparator Group · 1 Intervention: 18F-TPP · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,703 Previous Clinical Trials
30,853,058 Total Patients Enrolled

Eligibility Criteria

Age 21 - 80 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are healthy.
You are 21 to 80 years of age.